GO
Loading...

Health Care Equipment

More

  • May 20- Medtronic Inc said on Tuesday it agreed to pay royalties to rival medical device maker Edwards Lifesciences Corp in a settlement that allows Medtronic to continue to sell its CoreValve replacement heart valves.

  • AstraZeneca Chair: Shareholders, 'vote me away' Monday, 19 May 2014 | 11:14 AM ET

    As AstraZeneca's shares slid following its rejection of Pfizer's new bid, the company's chairman said he was "reasonably confident" it was the right decision.

  • Boston Scientific subpoenaed over heart device Friday, 9 May 2014 | 6:25 AM ET
    U.S. Department of Health and Human Services building, Washington, DC.

    Boston Scientific received a subpoena this week from the Department of Health and Human Services seeking information about its defibrillators.

  • Boston Scientific gets subpoena over defibrillators Thursday, 8 May 2014 | 11:37 PM ET

    May 8- Medical device maker Boston Scientific Corp said it received a subpoena this week from the Department of Health and Human Services seeking information about the performance of some of its implanted defibrillators. Boston Scientific, which competes with Medtronic Inc and St. Jude Medical Inc in selling ICDs, said it is cooperating with the request.

  • April 29- Boston Scientific Corp's quarterly revenue fell short of expectations due to lower sales of its implantable defibrillators and pacemakers, sending its shares down as much as 6 percent. Boston Scientific said it expected subcutaneous ICD sales of over $75 million in 2014..

  • UPDATE 1-Zimmer to buy Biomet in $13.35 bln deal Thursday, 24 Apr 2014 | 7:48 AM ET

    April 24- Medical device maker Zimmer Holdings Inc said it would buy orthopedic products company Biomet Inc in a deal valued at about $13.35 billion to broaden its portfolio of products that treat bone and joint-related disorders.

  • Zimmer to buy Biomet in $13.35 bln deal Thursday, 24 Apr 2014 | 7:18 AM ET

    April 24- Medical device maker Zimmer Holdings Inc said it would acquire orthopedic products company Biomet Inc in a deal valued at about $13.35 billion.

  • April 22- Intuitive Surgical Inc on Tuesday lowered its forecast for procedure growth for its da Vinci surgical robots, citing a slowdown in U.S. gynecology procedures. The medical device maker said it now expects da Vinci procedure growth in a range of 2 percent to 8 percent, down from the prior forecast of 9 percent to 12 percent.

  • April 22- The U.S. Food and Drug Administration on Tuesday proposed speeding up medical device approvals for patients who have no other treatment options through a new program focused on earlier and more frequent interactions between companies and FDA staff.

  • The proposed Expedited Access Premarket Approval Application program would feature earlier and more frequent interactions between companies and FDA staff. The program is not a new pathway to market, the FDA said, but rather a change in approach aimed at reducing the time it takes to develop a product and get it to market.

  • April 22- The U.S. Food and Drug Administration proposed on Tuesday a new, more collaborative approach for faster approval of high-risk medical devices intended to treat patients with serious conditions with no other treatment options.

  • April 15- U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

  • April 15- ConMed Corp, a surgical device maker that has been fighting off activist investors, is exploring a sale and has contacted large medical device companies to gauge their buyout interest, people familiar with the matter said on Tuesday.

  • J&J beats forecasts, helped by new medicines Tuesday, 15 Apr 2014 | 10:06 AM ET

    Johnson & Johnson turned in a solid first quarter Tuesday, topping analysts' profit and revenue estimates and increasing its 2014 earnings forecast by 5 cents a share.

  • April 14- Shares of medical device maker Medtronic Inc fell as much as 6 percent after a U.S. court temporarily halted sales of its aortic heart valve replacement system in the country.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- A non-surgically implanted heart valve meant to delay open heart surgery in children with congenital heart defects worked well for all but a few patients during a year of follow-up observation, in line with favorable results seen in original clinical trials of the Medtronic Inc product.

  • WASHINGTON, March 30- The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head study of the two, according to data from a small German trial presented at a major heart meeting on Sunday.

  • March 27- Alimera Sciences Inc said it has applied a fourth time for U.S. regulatory approval to start selling an eye implant that delivers a drug to treat a form of blindess in diabetes patients. The FDA asked for a new trial of the drug-device combination, but Alimera's partner, Psivida Corp, said that additional trials were not necessary.

  • Gates Foundation fighting dirty water deaths Monday, 24 Mar 2014 | 2:15 PM ET
    An exhibitor demonstrates the use of a toilet tap where water is recycled and reused, during the Reinvent The Toilet Fair in New Delhi on March  21, 2014.

    The Gates Foundation has awarded $2 million in grants to several Indian organizations to help improve sanitation by building a high-tech toilet.